Ascendis Health Director’s Associate Purchases 380,000 Shares in On-Market Transaction

Ascendis Share Purchase
  • Calibre Investment Holdings (Pty) Ltd, an associate of Ascendis Health director Theunis de Bruyn, acquires 380,000 shares in an on-market transaction.
  • The total value of the transaction amounts to R232,180.00, with each share priced at 61.10 cents.
  • The purchase demonstrates confidence in Ascendis Health’s future prospects and reflects a commitment to the company’s growth and success.

Ascendis Health Limited (ASC), a leading healthcare company in South Africa, has witnessed a notable transaction involving the acquisition of a substantial number of shares by an associate of one of its directors. Calibre Investment Holdings (Pty) Ltd, the associate company, purchased 380,000 ordinary shares in Ascendis Health at a price of 61.10 cents per share, resulting in a total transaction value of R232,180.00.

The transaction, which took place on 18 May 2023, signifies the associate’s confidence in Ascendis Health’s future prospects and underlines the positive outlook for the company’s growth trajectory and the value of its ordinary shares.

As per the Listings Requirements of the JSE Limited, Ascendis Health has fulfilled its disclosure obligations by providing comprehensive details of the transaction. The company has revealed that Theunis de Bruyn, a director and shareholder of Calibre Investment Holdings, had an indirect, beneficial interest in the purchase of Ascendis Health shares through this on-market transaction.

This acquisition of a significant number of shares by an associate of a director demonstrates a strong belief in Ascendis Health’s long-term potential. It further showcases the associate’s commitment to the company’s success and growth.

The clearance for this transaction was obtained in compliance with paragraph 3.66 of the JSE Limited Listings Requirements, ensuring transparency and adherence to regulatory guidelines.

Ascendis Health, a prominent player in the healthcare sector, has been dedicated to improving the well-being of South Africans since its inception. The company’s focus on delivering high-quality healthcare products and services includes pharmaceuticals, medical devices, consumer health, and wellness solutions.

The recent share acquisition by Calibre Investment Holdings reinforces Ascendis Health’s foundation as it continues to expand its market presence and drive innovation in the healthcare industry.

Visited 1 times, 1 visit(s) today

Stay ahead in the financial world – Sign Up to Rateweb’s essential newsletter for free. Get the latest insights on business trends, tech innovations, and market movements, directly to your inbox. Join our community of savvy readers and never miss an update that could impact your financial decisions.

Do you have a news tip for Rateweb reporters? Please email us at


Start trading with a free $30 bonus

Trade stocks, forex, commodities, metals and CFDs on stock indices with an internationally licensed and regulated broker. For all clients who open their first real account, XM offers a $30 trading bonus without any initial deposit needed. Learn more about how you can trade over 1000 instruments on the XM MT4 and MT5 platforms from your PC and Mac, or from a variety of mobile devices.


Personal Financial Tools

Below is a list of tools built to assist South Africans to make the best financial decisions:



South Africa’s primary source of financial tools and information

Contact Us


Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.